Lennon David James

CHIEF EXECUTIVE OFFICER

Lennon David James has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.

On the most recent filing, Lennon David James is listed as CHIEF EXECUTIVE OFFICER at Whitehawk Therapeutics, Inc. Inside the rolling window, Lennon David James reported no open-market purchases and 6 open-market sales totaling $1.1M in WHWK. The largest disclosed transaction in the window is a sale of 102,395 WHWK shares on Apr 6, 2026, worth $359K.

Companies traded

Other insiders at WHWK

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.1M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
WHWKSale$49KApr 10SEC ↗
WHWKSale$359KApr 8SEC ↗
WHWKSale$323KApr 8SEC ↗
WHWKSale$217KApr 8SEC ↗
WHWKSale$93KApr 3SEC ↗
WHWKSale$17KMar 10SEC ↗
Showing 1–6 of 6
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Lennon David James made?

Lennon David James has filed 5 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.

Which companies does Lennon David James trade?

Lennon David James has filed SEC Form 4 disclosures for 1 company, including WHWK.

When was Lennon David James's most recent SEC Form 4 filing?

Lennon David James's most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.

What is Lennon David James's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Lennon David James is listed as CHIEF EXECUTIVE OFFICER.

What is Lennon David James's total buy and sell value in the current window?

Inside the rolling retention window, Lennon David James bought $0 and sold $1.1M based on SEC Form 4 filings.

What was Lennon David James's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 102,395 WHWK shares on 2026-04-06, worth $359K, per SEC Form 4 filings.